Open AccessEfficacy and Safety of Apremilast in Patients With Moderate to Severe Plaque Psoriasis of the Scalp: Results of a Phase 3, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study
Author(s) -
Abby Van Voorhees,
Linda Stein Gold,
Mark Lebwohl,
et al
Publication year - 2019
Publication title -
skin the journal of cutaneous medicine
Language(s) - English
Resource type - Journals
ISSN - 2574-1624
DOI - 10.25251/skin.3.2.10
Subject(s) - medicine , placebo , apremilast , double blind , scalp , multicenter study , psoriasis , randomized controlled trial , dermatology , adverse effect , alternative medicine , pathology , psoriatic arthritis
not available. Disclosures: Study sponsored by Celgene.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom